🔗 Share this article

A shadow economy for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to the social media company, the platform has removed violative material and banned related keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

After moments of joining one group, a seller shared contact information, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant medical dangers”.